BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 163137)

  • 1. On the mechanism of hormone action in 7,12 dimethylbenz(a)anthracene-induced mammary tumor. I. Prolactin and progesterone effects on estrogen receptor in vitro.
    Sasaki GH; Leung BS
    Cancer; 1975 Mar; 35(3):645-51. PubMed ID: 163137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on insulin, prolactin, progesterone, and estradiol on DNA synthesis in organ culture of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Pasteels JL; Heuson JC; Heuson-Stiennon J; Legros N
    Cancer Res; 1976 Jul; 36(7 PT 1):2162-70. PubMed ID: 819126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-prolactin dependency in 7,12-dimethylbenz(a)anthracene-induced tumors.
    Leung BS; Sasaki GH; Leung JS
    Cancer Res; 1975 Mar; 35(3):621-7. PubMed ID: 163687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary adenocarcinoma induced in organ culture by 7,12-dimethylbenz(a)anthracene.
    Dao TL; Sinha D
    J Natl Cancer Inst; 1972 Aug; 49(2):591-3. PubMed ID: 5076832
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical characterization of carcinogen-induced mammary hyperplastic aveolar nodule and tumor in the rat.
    Dao TL; Chistakos SS; Varela R
    Cancer Res; 1975 May; 35(5):1128-34. PubMed ID: 164277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormones influencing postpartum growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    McCormick GM; Moon RC
    Cancer Res; 1967 Apr; 27(4):626-31. PubMed ID: 6025728
    [No Abstract]   [Full Text] [Related]  

  • 7. High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumors.
    Kelly PA; Asselin J; Caron MG; Raynaud JP; Labrie F
    Cancer Res; 1977 Jan; 37(1):76-81. PubMed ID: 187338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro interaction of estrogen and prolactin on hormone-dependent rat mammory tumors (38511).
    Lee C; Oyasu R; Chen C
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):224-6. PubMed ID: 165526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin stimulation of estrogen receptor in vitro in 7,12 dimethylbenz(A)anthracene-induced mammary tumor.
    Sasaki GH; Leung BS
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):409-12. PubMed ID: 4369071
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoradiographic localization of prolactin receptors in 7,12-dimethylbnez[a]anthracene-induced rat mammary carcinoma.
    Costlow ME; McGuire WL
    J Natl Cancer Inst; 1977 Apr; 58(4):1173-5. PubMed ID: 191627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
    Smith RD; Hilf R; Senior AE
    Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hormones and 7,12-dimethylbenz[a]anthracene on rat mammary tissue grown in organ culture.
    Koyama H; Sinha D; Dao TL
    J Natl Cancer Inst; 1972 Jun; 48(6):1671-80. PubMed ID: 5056255
    [No Abstract]   [Full Text] [Related]  

  • 13. On the mechanism of prolactin and estrogen action in 7,12 dimethylbenz(A)anthracene-induced mammary carcinoma in the rat. II. In vivo tumor responses and estrogen receptor.
    Leung BS; Sasaki GH
    Endocrinology; 1975 Sep; 97(3):564-72. PubMed ID: 170065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific estrogen binding in rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene.
    Boylan ES; Wittliff JL
    Cancer Res; 1975 Mar; 35(3):506-11. PubMed ID: 163681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone dependence in breast cancer.
    McGuire WL; Chamness GC; Costlow ME; Shepherd RE
    Metabolism; 1974 Jan; 23(1):75-100. PubMed ID: 4357247
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased DNA binding of the estrogen receptor in an estrogen-resistant mammary cancer.
    Baskevitch PP; Vignon F; Bousquet C; Rochefort H
    Cancer Res; 1983 May; 43(5):2290-7. PubMed ID: 6403233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone-stimulated growth of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in neonatally androgenized rats.
    Yoshida H; Fukunishi R; Kato Y; Matsumoto K
    J Natl Cancer Inst; 1980 Oct; 65(4):823-8. PubMed ID: 6775121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of casein-producing and -nonproducing cell populations from 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
    Johnson ML; Levy J; Rosen JM
    Cancer Res; 1983 May; 43(5):2199-209. PubMed ID: 6187446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hypophysectomy and hormone replacement of hormone receptor levels and the growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
    Arafah BM; Manni A; Pearson OH
    Endocrinology; 1980 Nov; 107(5):1364-9. PubMed ID: 6253265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.